Compare NPKI & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NPKI | CBLL |
|---|---|---|
| Founded | 1932 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 935.3M |
| IPO Year | 1995 | 2024 |
| Metric | NPKI | CBLL |
|---|---|---|
| Price | $8.40 | $26.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | $16.33 | ★ $31.57 |
| AVG Volume (30 Days) | ★ 1.1M | 549.6K |
| Earning Date | 10-29-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 126.16 | 56.93 |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $747,763,000.00 | $89,063,000.00 |
| Revenue This Year | $9.35 | $30.06 |
| Revenue Next Year | $12.61 | $27.51 |
| P/E Ratio | $25.58 | ★ N/A |
| Revenue Growth | ★ 58.59 | 36.09 |
| 52 Week Low | $8.24 | $13.20 |
| 52 Week High | $16.50 | $28.89 |
| Indicator | NPKI | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 26.75 | 50.61 |
| Support Level | $8.24 | $22.73 |
| Resistance Level | $15.06 | $28.50 |
| Average True Range (ATR) | 0.53 | 1.58 |
| MACD | -0.03 | -0.20 |
| Stochastic Oscillator | 5.30 | 67.52 |
NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom. It generates maximum revenue from United States.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.